Navigation Links
New company announcement: TERGUS PHARMA
Date:6/12/2012

RESEARCH TRIANGLE PARK, N.C., June 12, 2012 /PRNewswire-iReach/ -- In response to company growth and expansion of topical pharmaceutical product development services, Analytical Solutions, Inc. (ASI) is pleased to announce today that it is changing its name to Tergus Pharma, LLC, to better echo the company's new growth trajectory.

Tergus Co-Founder and CEO, Dr. Vijendra NALAMOTHU, most recently Head of Dermatology R&D for Promius Pharma and Dr. Reddy's Laboratories, brings 18 years of topical drug product development and commercialization experience to Tergus clients. Since 1994, Tergus Co-Founder and President, Dr. Kailas Thakker, has been providing quality analytical services to the pharmaceutical industry with an emphasis on In Vitro Release Testing (IVRT), functional testing for semisolids and topical products.

Tergus (Latin for "skin") is now providing dermatology drug development services from concept to commercialization.  With the acquisition of new equipment and strategic additions to the scientific team, Tergus Pharma is pleased to announce that it is now servicing its clients with a broader range of topical drug development services, including product development strategy & design; target product profile development; formulation development; analytical method development & validation; preclinical & clinical supplies manufacturing; program management & logistics leadership; scale-up & technology transfer oversight; regulatory CMC consulting; disease model development; clinical development strategy; and development plan creation to ensure fastest path to in vivo or clinical proof of concept studies.

Tergus' core expertise will remain focused in topical dosage forms, including creams, ointments, lotions, liquids, suspensions, gels, hydrogels, pastes, pump sprays, topical aerosols, foams, microencapsulation, liposomes, suppositories and nail lacquers.

Think Topicals. Think Tergus

About Tergus Pharma

Tergus Pharma, LLC is a privately held dermatology-focused organization offering complete pharmaceutical product development services. Tergus' GMP/GLP compliant, state of the art laboratories are located in Research Triangle Park, North Carolina. For additional information please visit www.TergusPharma.com 

Media Contact: Ms. Kathy Meserve, Tergus Pharma, +1(919) 549-9700 Ext.105, KMeserve@TergusPharma.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Tergus Pharma
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Company To Present At The William Blair Growth Stock Conference
2. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
3. Masimo to Present at William Blair & Company 32nd Annual Growth Stock Conference
4. K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity
5. CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference
6. Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series
7. Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager
8. Perrigo Company to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference
9. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
10. The Female Health Company Reports Second Quarter Operating Results
11. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Dec. 2, 2016  Maxor National Pharmacy Services, LLC ("Maxor"), ... Specialties, Inc. ("PSI").  The combination of Texas ... -based PSI bring together both company,s clinical expertise and ... payers an industry-leading specialty pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... MARLBOROUGH, Mass. , Dec. 2, 2016 ... announced a definitive agreement to acquire certain manufacturing assets ... NVCN ) (TSX: NVC) advanced biological tissue business, as ... a total of $75 million in cash. The Neovasc ... heart valves, including the Boston Scientific Lotus™ Valve System. ...
(Date:12/2/2016)... MONMOUTH JUNCTION, N.J. , Dec. 2, 2016 /PRNewswire/ ... critical care immunotherapy leader commercializing its European Union approved ... in critically-ill and cardiac surgery patients worldwide, announced that ... present at the 9th Annual LD Micro Main ... 8 th , 2016 at the Luxe Sunset Boulevard ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... For over twenty-four years, Doctors on Liens ... personal injury victims find high quality medical care. When the company started in 1997, ... Fast forward to present day and the now ten-page directory features a vast array of ...
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to host ... other developmental disabilities. The group, which is being launched with the help of Robbie ... share stories and advice, seek help, and continue their education on how to best ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s ... ostomy patients, standing as living proof that attitude and determination can combine into ... issues that spike around the holidays. This campaign will offer patients a new-found ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and ... storing, shipping and disposal. The new version is a faster and a more ...
(Date:12/2/2016)... ... ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology that measures ... on the market can deliver all that rejiva can. , “Rejiva promotes relaxation and ... than the usual heart rate and steps taken”, adds Evens Augustin, CEO of Rijuven. ...
Breaking Medicine News(10 mins):